Aniracetam is a racetamic and Ampakine drug that is slightly higher in potency than Piracetam. It was developed in the 1970's by chemist,
Hoffmann La-Roche and can be synthesized by reacting GABA or
2-Pyrrolidone with Anisoyl choloride. Aniracetam is fat soluble and its
half-life is considerably shorter than the other racetams. The substance
was used as parent compound to help create the new nootropic Ampakine
drug class.
RacetamANIRACETAM BENEFITS
As stated above, Aniracetam can have many off-label uses. It is considered a fairly safe and low toxicity substance to improve cognition
and memory or reduce anxiety symptoms. Like other racetams, it can have
an added benefit of reducing free radicals and oxidative stress in the
brain which can lead to degenerative diseases and neurological
complications. It should not be used as a main line of defence or
treatment for degenerative diseases like Alzheimer's and Dementia but
may have merit in reducing some of the symptoms associated. Below, are
some of the common observed benefits of Aniracetam. Results may vary.
Improved Memory
Increased Learning Ability
Improved Cognitive Processing
Heightened Reflexes
Heightened Perception
Reduced Anxiety
Reduced Depression
If you suffer from a medical condition, do not use Aniracetam as a primary therapy. It may be used in conjunction with other therapies
however it is always recommended to consult a licensed medical
professional prior to administration. Limited data about side effects
and interactions have been recorded and safety should be evaluated by a
doctor before on or off-label usage.
